Author name: onco2018_admin

Potential new treatment options for HER2-low and HER2-negative breast cancer patients Summary More options for HER2-low and HER2-negative patients Two drugs, Enhertu and Trodelvy, should provide more target therapy options for breast cancer patients with HER2-negative and HER2-low diagnoses. In general, treatment options for HER2-negative patients with positive estrogen and progesterone (HR-positive) may be limited […]

How do you make a cancer treatment decision? It would be best if you chose your cancer treatment based on your decision. You will regret it if you let someone else decide for you, regardless of your treatment outcome.  The most crucial action is knowing your value and how you want to live. It does